Posted inComunicati
World’s First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceutical
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE CHONGQING, China, April 28, 2026 /PRNewswire/ -- Chongqing Claruvis Pharmaceutical…
Continue Reading














